Monday, January 30, 2017

BRIEF-Incyte and Calithera Biosciences announce global collaboration to develop and commercialize CB-1158

* Incyte and calithera biosciences announce global

collaboration to develop and commercialize CB-1158, a

first-in-class, small molecule arginase inhibitor

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)